Literature DB >> 19410551

SnapShot: MicroRNAs in Cancer.

Riccardo Spizzo1, Milena S Nicoloso, Carlo M Croce, George A Calin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19410551     DOI： 10.1016/j.cell.2009.04.040

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  106 in total

1.  Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.

Authors:  Li Li Lin; Wei Wang; ZhaoYang Hu; Li Wen Wang; Jing Chang; HanGuang Qian
Journal:  Med Oncol       Date:  2014-11-04       Impact factor: 3.064

Review 2.  MicroRNA binding-site polymorphisms as potential biomarkers of cancer risk.

Authors:  Rachel C Blitzblau; Joanne B Weidhaas
Journal:  Mol Diagn Ther       Date:  2010-12-01       Impact factor: 4.074

3.  Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.

Authors:  Milena S Nicoloso; Hao Sun; Riccardo Spizzo; Hyunsoo Kim; Priyankara Wickramasinghe; Masayoshi Shimizu; Sylwia E Wojcik; Jana Ferdin; Tanja Kunej; Lianchun Xiao; Siranoush Manoukian; Giorgio Secreto; Fernando Ravagnani; Xuemei Wang; Paolo Radice; Carlo M Croce; Ramana V Davuluri; George A Calin
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

4.  MicroRNA expression signatures of stage, grade, and progression in clear cell RCC.

Authors:  Banumathy Gowrishankar; Ilsiya Ibragimova; Yan Zhou; Michael J Slifker; Karthik Devarajan; Tahseen Al-Saleem; Robert G Uzzo; Paul Cairns
Journal:  Cancer Biol Ther       Date:  2013-12-18       Impact factor: 4.742

Review 5.  Regulating miRNA by natural agents as a new strategy for cancer treatment.

Authors:  Sajiv Sethi; Yiwei Li; Fazlul H Sarkar
Journal:  Curr Drug Targets       Date:  2013-09       Impact factor: 3.465

6.  Genetic variants in RAN, DICER and HIWI of microRNA biogenesis genes and risk of cervical carcinoma in a Chinese population.

Authors:  Jiaping Chen; Zhenzhen Qin; Shandong Pan; Jie Jiang; Li Liu; Jibin Liu; Xiaojun Chen; Zhibin Hu; Hongbing Shen
Journal:  Chin J Cancer Res       Date:  2013-10       Impact factor: 5.087

Review 7.  MicroRNAs and other non-coding RNAs as targets for anticancer drug development.

Authors:  Hui Ling; Muller Fabbri; George A Calin
Journal:  Nat Rev Drug Discov       Date:  2013-11       Impact factor: 84.694

Review 8.  The therapeutic potential of microRNAs: disease modulators and drug targets.

Authors:  Ailbhe M McDermott; Helen M Heneghan; Nicola Miller; Michael J Kerin
Journal:  Pharm Res       Date:  2011-08-05       Impact factor: 4.200

9.  miR-888 is an expressed prostatic secretions-derived microRNA that promotes prostate cell growth and migration.

Authors:  Holly Lewis; Raymond Lance; Dean Troyer; Hind Beydoun; Melissa Hadley; Joseph Orians; Tiffany Benzine; Kenya Madric; O John Semmes; Richard Drake; Aurora Esquela-Kerscher
Journal:  Cell Cycle       Date:  2013-11-07       Impact factor: 4.534

10.  Prognostic role of circulating exosomal miRNAs in multiple myeloma.

Authors:  Salomon Manier; Chia-Jen Liu; Hervé Avet-Loiseau; Jihye Park; Jiantao Shi; Federico Campigotto; Karma Z Salem; Daisy Huynh; Siobhan V Glavey; Bradley Rivotto; Antonio Sacco; Aldo M Roccaro; Juliette Bouyssou; Stéphane Minvielle; Philippe Moreau; Thierry Facon; Xavier Leleu; Edie Weller; Lorenzo Trippa; Irene M Ghobrial
Journal:  Blood       Date:  2017-02-17       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.